MSS mCRC | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

6,207 results for “MSS mCRC”

Trials

View all 5058 →

Active, not recruiting

Nivolumab+Ipilimumab+RT in MSS mCRC

32 participants · First posted Oct 5, 2020

BrUOG 379 Phase Ib/II Trial ONC201 + Nivolumab in MSS mCRC

13 participants · First posted Jan 2, 2019

Radiotherapy in Combination With Sintilimab，GM-CSF and Fruquintinib in Patients With MSS mCRC

71 participants · First posted Mar 23, 2022

Drugs

View all 433 →

Colorectal cancer (MSS) (BreakBio)

monoclonal antibody

Porustobart

Msc-2b(M's Science)

Organizations

View all 68 →

Cardiff Oncology

United States

MDRC

United States

Decramer Marc

Belgium

News

View all 648 →

ICI Combinations Show Survival Benefits in Heavily Pretreated MSS mCRC

TREOS Bio Reports Six-Year Cancer-Free Survival in MSS mCRC Patient Treated with PolyPEPI1018 Off-the-Shelf Immunotherapy

KEYFORM-007 Trial: Favezelimab/Pembrolizumab Combo Fails in MSS mCRC

Page 1 of 621